Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Cytomegalovirus Vaccines

Known as: Cytomegalovirus Vaccines [Chemical/Ingredient], Vaccines, Cytomegalovirus 
Vaccines or candidate vaccines used to prevent infection with CYTOMEGALOVIRUS.
National Institutes of Health

Related topics

Related topics

8 relations
In BloodProcess of secretionagonistsantagonists & inhibitors
Expand

Narrower (1)

V-5 immunitor

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Serologic Status of Routine Childhood Vaccines, Cytomegalovirus, and Epstein-Barr Virus in Children With Inflammatory Bowel Disease.
BACKGROUND Data on the serologic status of childhood vaccines, cytomegalovirus (CMV) and Epstein-Barr virus (EBV), are limited in… 
2017
2017
New Vaccines in Pipeline Development
Group B streptococcus vaccines Cytomegalovirus vaccines Respiratory syncytial virus vaccines 
Review
2011
Review
2011
A novel high-throughput neutralization assay for supporting clinical evaluations of human cytomegalovirus vaccines.
Neutralizing antibodies are considered an important component of protective immunity against congenital infection of human… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2011
2011
Neutralizing Activity of Saliva against Cytomegalovirus
ABSTRACT Congenital cytomegalovirus (CMV) disease is the leading cause of permanent disability in neonates in the United States… 
2010
2010
Can we build it better? Using BAC genetics to engineer more effective cytomegalovirus vaccines.
  • M. Schleiss
  • The Journal of clinical investigation
  • 2010
  • Corpus ID: 29388616
The magnitude and durability of immunity to human cytomegalovirus (HCMV) following natural infection is compromised by the… 
  • table 1
  • figure 1
  • figure 2
2009
2009
A live guinea pig cytomegalovirus vaccine deleted of three putative immune evasion genes is highly attenuated but remains immunogenic in a vaccine/challenge model of congenital cytomegalovirus…
Live attenuated vaccines for prevention of congenital cytomegalovirus infections encode numerous immune evasion genes. Their… 
  • figure 1
  • table 1
  • figure 5
  • figure 3
  • figure 4
2007
2007
Human cytomegalovirus vaccines -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis
Review
2005
Review
2005
Progress toward an elusive goal: current status of cytomegalovirus vaccines
Although infection with human cytomegalovirus (CMV) is ubiquitous and generally asymptomatic in most individuals, certain patient… 
Review
2005
Review
2005
Immunisation in the current management of cystic fibrosis patients.
Although no special recommendations exist, clearly patients with cystic fibrosis (CF) can benefit from immunisation. We reviewed… 
  • table 1
  • table 2
  • table 3
Highly Cited
1996
Highly Cited
1996
Mucosal antibodies to human cytomegalovirus glycoprotein B occur following both natural infection and immunization with human cytomegalovirus vaccines.
Because antibodies against human cytomegalovirus (HCMV) glycoprotein B (gB) neutralize, levels of IgG, secretory IgA (sIgA), and… 
  • figure 1
  • figure 2
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE